Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature

Bisphosphonates (BPs) are a class of drugs used to treat osteoporosis and malignant bone metastasis. BPs show high binding capacity to the bone matrix, especially in sites of active bone metabolism. The American Society for Bone and Mineral Research defines BRONJ as “an area of exposed bone in the m...

Full description

Saved in:
Bibliographic Details
Main Authors: Eder Alberto Sigua-Rodriguez, Renato da Costa Ribeiro, Ana Caroline Ramos de Brito, Natalia Alvarez-Pinzon, José Ricardo de Albergaria-Barbosa
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:International Journal of Dentistry
Online Access:http://dx.doi.org/10.1155/2014/192320
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552182726000640
author Eder Alberto Sigua-Rodriguez
Renato da Costa Ribeiro
Ana Caroline Ramos de Brito
Natalia Alvarez-Pinzon
José Ricardo de Albergaria-Barbosa
author_facet Eder Alberto Sigua-Rodriguez
Renato da Costa Ribeiro
Ana Caroline Ramos de Brito
Natalia Alvarez-Pinzon
José Ricardo de Albergaria-Barbosa
author_sort Eder Alberto Sigua-Rodriguez
collection DOAJ
description Bisphosphonates (BPs) are a class of drugs used to treat osteoporosis and malignant bone metastasis. BPs show high binding capacity to the bone matrix, especially in sites of active bone metabolism. The American Society for Bone and Mineral Research defines BRONJ as “an area of exposed bone in the maxillofacial region that has not healed within 8 weeks after identification by a healthcare provider in a patient who is receiving or has been exposed to a bisphosphonate and has not had radiation therapy to the craniofacial region.” Bisphosphonate-related osteonecrosis of the jaw (BRONJ) can adversely affect quality of life, as it may produce significant morbidity. The American Association of Oral and Maxillofacial Surgeons (AAOMS) considers as vitally important that information on BRONJ be disseminated to other dental and medical specialties. The purpose of this work is to offer a perspective on how dentists should manage patients on BPs, to show the benefits of accurately diagnosing BRONJ, and to present diagnostic aids and treatments strategies for the condition.
format Article
id doaj-art-c4a20cc3d34341e0bd3bdfc759c1d06f
institution Kabale University
issn 1687-8728
1687-8736
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series International Journal of Dentistry
spelling doaj-art-c4a20cc3d34341e0bd3bdfc759c1d06f2025-02-03T05:59:20ZengWileyInternational Journal of Dentistry1687-87281687-87362014-01-01201410.1155/2014/192320192320Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the LiteratureEder Alberto Sigua-Rodriguez0Renato da Costa Ribeiro1Ana Caroline Ramos de Brito2Natalia Alvarez-Pinzon3José Ricardo de Albergaria-Barbosa4Department of Oral and Maxillofacial Surgery, Piracicaba Dental School, P.O. Box 52, University of Campinas (UNICAMP), 13414-903 Piracicaba, SP, BrazilDepartment of Oral and Maxillofacial Surgery, Piracicaba Dental School, P.O. Box 52, University of Campinas (UNICAMP), 13414-903 Piracicaba, SP, BrazilDepartment of Dental Radiology, Piracicaba Dental School, P.O. Box 52, University of Campinas (UNICAMP), 13414-903 Piracicaba, SP, BrazilDepartment of Prosthesis and Periodontology, Piracicaba Dental School, P.O. Box 52, University of Campinas (UNICAMP), 13414-903 Piracicaba, SP, BrazilDepartment of Oral and Maxillofacial Surgery, Piracicaba Dental School, P.O. Box 52, University of Campinas (UNICAMP), 13414-903 Piracicaba, SP, BrazilBisphosphonates (BPs) are a class of drugs used to treat osteoporosis and malignant bone metastasis. BPs show high binding capacity to the bone matrix, especially in sites of active bone metabolism. The American Society for Bone and Mineral Research defines BRONJ as “an area of exposed bone in the maxillofacial region that has not healed within 8 weeks after identification by a healthcare provider in a patient who is receiving or has been exposed to a bisphosphonate and has not had radiation therapy to the craniofacial region.” Bisphosphonate-related osteonecrosis of the jaw (BRONJ) can adversely affect quality of life, as it may produce significant morbidity. The American Association of Oral and Maxillofacial Surgeons (AAOMS) considers as vitally important that information on BRONJ be disseminated to other dental and medical specialties. The purpose of this work is to offer a perspective on how dentists should manage patients on BPs, to show the benefits of accurately diagnosing BRONJ, and to present diagnostic aids and treatments strategies for the condition.http://dx.doi.org/10.1155/2014/192320
spellingShingle Eder Alberto Sigua-Rodriguez
Renato da Costa Ribeiro
Ana Caroline Ramos de Brito
Natalia Alvarez-Pinzon
José Ricardo de Albergaria-Barbosa
Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
International Journal of Dentistry
title Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
title_full Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
title_fullStr Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
title_full_unstemmed Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
title_short Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
title_sort bisphosphonate related osteonecrosis of the jaw a review of the literature
url http://dx.doi.org/10.1155/2014/192320
work_keys_str_mv AT ederalbertosiguarodriguez bisphosphonaterelatedosteonecrosisofthejawareviewoftheliterature
AT renatodacostaribeiro bisphosphonaterelatedosteonecrosisofthejawareviewoftheliterature
AT anacarolineramosdebrito bisphosphonaterelatedosteonecrosisofthejawareviewoftheliterature
AT nataliaalvarezpinzon bisphosphonaterelatedosteonecrosisofthejawareviewoftheliterature
AT josericardodealbergariabarbosa bisphosphonaterelatedosteonecrosisofthejawareviewoftheliterature